Zhihua Yao

678 total citations
54 papers, 453 citations indexed

About

Zhihua Yao is a scholar working on Pathology and Forensic Medicine, Oncology and Surgery. According to data from OpenAlex, Zhihua Yao has authored 54 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pathology and Forensic Medicine, 21 papers in Oncology and 9 papers in Surgery. Recurrent topics in Zhihua Yao's work include Lymphoma Diagnosis and Treatment (23 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Viral-associated cancers and disorders (6 papers). Zhihua Yao is often cited by papers focused on Lymphoma Diagnosis and Treatment (23 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Viral-associated cancers and disorders (6 papers). Zhihua Yao collaborates with scholars based in China, United States and Japan. Zhihua Yao's co-authors include Shuna Yao, Yanyan Liu, Junfeng Chu, Zheng Yan, Haiying Wang, Haiying Wang, Shujun Yang, Yuanlin Xu, Wenping Zhou and Ying Liu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Zhihua Yao

46 papers receiving 445 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhihua Yao China 12 222 131 124 116 83 54 453
Jong Sun Choi South Korea 14 178 0.8× 139 1.1× 119 1.0× 108 0.9× 67 0.8× 24 481
Qingguo Yan China 15 153 0.7× 209 1.6× 144 1.2× 82 0.7× 79 1.0× 43 583
Shuna Yao China 10 141 0.6× 86 0.7× 90 0.7× 70 0.6× 40 0.5× 30 271
Ying Yuan China 20 212 1.0× 119 0.9× 110 0.9× 97 0.8× 196 2.4× 54 989
Zhefeng Liu China 14 382 1.7× 137 1.0× 55 0.4× 235 2.0× 57 0.7× 36 615
Jongmin Sim South Korea 15 122 0.5× 239 1.8× 56 0.5× 66 0.6× 75 0.9× 49 534
Richard D. Hall United States 16 343 1.5× 220 1.7× 44 0.4× 175 1.5× 176 2.1× 54 809
Da Zhang China 9 165 0.7× 93 0.7× 34 0.3× 109 0.9× 62 0.7× 34 391
Yen‐Chun Liu United States 15 105 0.5× 180 1.4× 112 0.9× 34 0.3× 46 0.6× 49 586
Xuan Meng China 11 149 0.7× 215 1.6× 39 0.3× 101 0.9× 132 1.6× 32 509

Countries citing papers authored by Zhihua Yao

Since Specialization
Citations

This map shows the geographic impact of Zhihua Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhihua Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhihua Yao more than expected).

Fields of papers citing papers by Zhihua Yao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhihua Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhihua Yao. The network helps show where Zhihua Yao may publish in the future.

Co-authorship network of co-authors of Zhihua Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Zhihua Yao. A scholar is included among the top collaborators of Zhihua Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhihua Yao. Zhihua Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cao, Bo, et al.. (2025). UWB Sensors Optimization Deployment for Narrow and Long Space Environments. IEEE Access. 13. 32497–32510. 1 indexed citations
2.
3.
Yao, Zhihua, et al.. (2024). Determinants of family firm IPO underpricing: Evidence from Japan. Japan and the World Economy. 73. 101294–101294.
4.
Zhao, Weili, Jun Zhu, Yuqin Song, et al.. (2024). Tucidinostat plus R-CHOP in previously untreated diffuse large B-cell lymphoma with double expression of MYC and BCL2: An interim analysis from the phase III DEB study.. Journal of Clinical Oncology. 42(17_suppl). LBA7003–LBA7003. 7 indexed citations
5.
Liu, Yanyan, Ningjing Lin, Zhihua Yao, et al.. (2024). Phase I safety and preliminary efficacy of IMM0306 in combination with lenalidomide in patients with relapsed or refractory CD20-positive B-cell non-Hodgkin's lymphoma.. Journal of Clinical Oncology. 42(16_suppl). e19040–e19040. 1 indexed citations
6.
Yang, Yujiao, et al.. (2024). Severe inflammation in C57/BL6 mice leads to prolonged cognitive impairment by initiating the IL-1β/TRPM2 pathway. International Immunopharmacology. 128. 111380–111380. 5 indexed citations
7.
Yan, Zheng, Shuna Yao, Haiying Wang, et al.. (2023). Low incidence of hepatitis B virus reactivation in patients with hematological malignancies receiving novel anticancer drugs: A report from a high epidemic area and literature review. Journal of Microbiology Immunology and Infection. 56(4). 747–756. 1 indexed citations
8.
Yan, Zheng, Shuna Yao, Zhizhong Wang, et al.. (2023). Treatment of extranodal NK/T-cell lymphoma: From past to future. Frontiers in Immunology. 14. 1088685–1088685. 8 indexed citations
9.
Yao, Shuna, Zhihua Yao, Yan Zheng, et al.. (2023). Preliminary Results of a Phase Ⅱ Study of Lenalidomide Combined with Immunochemotherapy in Patients with Primary Central Nervous System Lymphoma. Blood. 142(Supplement 1). 1758–1758. 1 indexed citations
10.
11.
Liu, Yanyan, et al.. (2022). A retrospective cohort study of polatuzumab vedotin combined with immunochemotherapy in Chinese patients with relapse/refractory diffuse large B cell lymphoma. Annals of Translational Medicine. 10(19). 1070–1070. 2 indexed citations
12.
Yao, Zhihua, Yan Zheng, Shuna Yao, et al.. (2022). Preliminary Results of a Phase Ⅱ Study of Zanubrutinib Combined with Immunochemotherapy in Patients with CD79A/CD79B-Mutant Diffuse Large B-Cell Lymphoma. Blood. 140(Supplement 1). 3767–3768. 1 indexed citations
13.
Huang, Huiqiang, Zengjun Li, Gang Cheng, et al.. (2021). Prophylaxis of Neutropenia with Mecapegfilgrastim in Patients with Hematologic Malignancies. Blood. 138(Supplement 1). 4569–4569.
14.
Li, Jiayin, Xiaoyin Liu, Zhihua Yao, & Mingzhi Zhang. (2020). <p>High-Grade B-Cell Lymphomas, Not Otherwise Specified: A Study of 41 Cases</p>. Cancer Management and Research. Volume 12. 1903–1912. 19 indexed citations
15.
Yan, Zheng, Shuna Yao, Yanyan Liu, et al.. (2020). Durable Response to Sintilimab and Chidamide in a Patient With Pegaspargase- and Immunotherapy-Resistant NK/T-Cell Lymphoma: Case Report and Literature Review. Frontiers in Oncology. 10. 608304–608304. 20 indexed citations
16.
Wang, Haiying, Junfeng Chu, Peng Zhang, et al.. (2020). <p>Safety and Efficacy of Chemotherapy Combined with Anlotinib Plus Anlotinib Maintenance in Chinese Patients with Advanced/Metastatic Soft Tissue Sarcoma</p>. OncoTargets and Therapy. Volume 13. 1561–1568. 40 indexed citations
17.
Yao, Zhihua, Yuan Tian, Haiying Wang, et al.. (2017). MMP-2 together with MMP-9 overexpression correlated with lymph node metastasis and poor prognosis in early gastric carcinoma. Tumor Biology. 39(6). 3726131641–3726131641. 52 indexed citations
18.
Yu, Jingwei, Boris Bartholdy, Zijun Y. Xu‐Monette, et al.. (2016). An oxidative stress-based mechanism of doxorubicin cytotoxicity suggests new therapeutic strategies in ABC-DLBCL. Blood. 128(24). 2797–2807. 48 indexed citations
19.
Liu, Yanyan, Shuna Yao, Zhihua Yao, et al.. (2015). MicroRNAs are Related to Rituximab in Combination with Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Resistance in Patients with Diffuse Large B-cell Lymphoma. SHILAP Revista de lepidopterología. 1(1). 6–6. 5 indexed citations
20.
Yao, Zhihua, et al.. (2009). Analysis of clinical data and prognosis for 24 patients with primary parotid malignant lymphoma. 18(10). 616–618. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jong Sun Choi Breakdown of academic impact, for papers by Qingguo Yan Breakdown of academic impact, for papers by Shuna Yao Breakdown of academic impact, for papers by Ying Yuan Breakdown of academic impact, for papers by Zhefeng Liu Breakdown of academic impact, for papers by Jongmin Sim Breakdown of academic impact, for papers by Richard D. Hall Breakdown of academic impact, for papers by Da Zhang Breakdown of academic impact, for papers by Yen‐Chun Liu Breakdown of academic impact, for papers by Xuan Meng
Rankless by CCL
2026